TITLE

Novel strategies to treat antiretroviral-naive HIV-infected patients

AUTHOR(S)
Dunning, Jake; Nelson, Mark
PUB. DATE
October 2009
SOURCE
Journal of Antimicrobial Chemotherapy (JAC);Oct2009, Vol. 64 Issue 4, p674
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Although guidelines exist that provide recommended strategies for treating HIV-infected patients who are naive to antiretroviral therapy, treatment needs to be tailored to individual circumstances. Here we discuss the current recommendations and the evidence used in their development, along with new and emerging treatment strategies.
ACCESSION #
44592260

 

Related Articles

  • Clinical Performance of a Dermal Filler Containing Natural Glycolic Acid and a Polylactic Acid Polymer. Tagle, Jorge M.; Macchetto, Pedro Cervantes; Páramo, Rosa Margarita Durán // Journal of Clinical & Aesthetic Dermatology;Feb2010, Vol. 3 Issue 2, p42 

    Lipoatrophy is a condition that affects certain individuals, most commonly those who are infected with the human immunodeficiency virus. Injectable fillers are used for the treatment of these dermal contour deformities to smooth dermal depressions formed by the loss of volume. These dermal...

  • Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal. Shigdel, Rajesh; Klouman, Elise; Bhandari, Anita; Ahmed, Luai A. // HIV/AIDS - Research & Palliative Care;2014, Vol. 6, p109 

    Purpose: There are a high number of HIV-infected patients receiving antiretroviral therapy (ART) in the Kathmandu District of Nepal, but information on adherence and factors influencing it are scarce in this population. The present study aimed to estimate ART adherence among HIV-infected...

  • Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? Shihab, Hasan M.; Lutwama, Fred; Piloya, Theresa; Castelnuovo, Barbara; Kambugu, Andrew D.; Colebunders, Robert // Journal of Infection in Developing Countries;2009, Vol. 3 Issue 5, p405 

    A large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with...

  • Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review. Cota, Gláucia F.; Sousa, Marcos R. de; Rabello, Ana // PLoS Neglected Tropical Diseases;Jun2011, Vol. 5 Issue 6, p1 

    Background and Objectives: Visceral leishmaniasis (VL) is a common complication in AIDS patients living in Leishmaniaendemic areas. Although antiretroviral therapy has changed the clinical course of HIV infection and its associated illnesses, the prevention of VL relapses remains a challenge for...

  • Increased risk of deep neck infection among HIV-infected patients in the era of highly active antiretroviral therapy--a population-based follow-up study. Ching-Feng Liu; Shih-Feng Weng; Yung-Song Lin; Chih-Sheng Lin; Ching-Feng Lien; Jhi-Joung Wang // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: Deep neck infections (DNIs) in HIV-infected patients often produce severe complications, even death. Data on the incidence rates and risks of DNI among HIV-infected patients are scarce, particularly with the widespread use of highly active antiretroviral therapy (HAART). We evaluated...

  • Quantifying HIV for Monitoring Antiretroviral Therapy in Resource-Poor Settings. Stevens, Wendy S.; Scott, Lesley E.; Crowe, Suzanne M. // Journal of Infectious Diseases;4/15/2010 Supplement 1, Vol. 201, pS16 

    There is increasing evidence to support the inability of CD4 cell count monitoring to predict virological failure in human immunodeficiency virus-infected individuals receiving antiretroviral therapy. There is renewed interest in improving access to viral load monitoring in resource-constrained...

  • Review of antiretroviral agents for the treatment of HIV infection. Stanic, Anela; Grana, Julie C. // Formulary;Feb2009, Vol. 44 Issue 2, p47 

    Research into the treatment of HIV infection has resulted in the development of 5 antiretroviral (ARV) drug classes: entry inhibitors, including fusion inhibitors and chemokine coreceptor (CCR) inhibitors; nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs); non-nucleoside reverse...

  • The Evolution of Coreceptor Tropism in HIV-infected Patients Interrupting Suppressive Antiretroviral Therapy. Waters, Laura J.; Scourfield, Andrew T.; Marcano, Marie; Gazzard, Brian G.; Bower, Mark; Nelson, Mark; Stebbing, Justin // Clinical Infectious Diseases;3/1/2011, Vol. 52 Issue 5, p671 

    CCR5 antagonists may provide a well-tolerated switch option for patients experiencing tolerability or toxicity of their antiretroviral regimen. We analyzed stored samples from patients undergoing planned treatment interruptions for reasons other than virological failure, in order to analyze...

  • Adherence to Highly Active Antiretroviral Treatment in HIV-Infected Rwandan Women. Musiime, Stephenson; Muhairwe, Fred; Rutagengwa, Alfred; Mutimura, Eugene; Anastos, Kathryn; Hoover, Donald R.; Qiuhu, Shi; Munyazesa, Elizaphane; Emile, Ivan; Uwineza, Annette; Cowan, Ethan // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Background: Scale-up of highly active antiretroviral treatment therapy (HAART) programs in Rwanda has been highly successful but data on adherence is limited. We examined HAART adherence in a large cohort of HIV+ Rwandan women. Methods: The Rwanda Women's Interassociation Study Assessment...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics